ABSTRACT
Atherosclerosis is a global disease with an extremely high morbidity and fatality rate, so it is necessary to develop effective treatments to reduce its impact. In this work, we successfully prepared a multifunctional drug-loaded nano-delivery system with pH-responsive, CD44-targeted, and chemical-photothermal synergistic treatment. Dendritic mesoporous silica nanoparticles capped with copper sulfide (CuS) were synthesized via an oil-water biphase stratification reaction system; these served as the carrier material and encapsulated the anticoagulant drug heparin (Hep). The pH-sensitive Schiff base bond was used as a gatekeeper and targeting agent to modify hyaluronic acid (HA) on the surface of the nanocarrier. HA coating endowed the nanocomposite with the ability to respond to pH and target CD44-positive inflammatory macrophages. Based on this multifunctional nanocomposite, we achieved precise drug delivery, controlled drug release, and chemical-photothermal synergistic treatment of atherosclerosis. The in vitro drug release results showed that the nanocarriers exhibited excellent drug-controlled release properties, and could release drugs in the weakly acidic microenvironment of atherosclerotic inflammation. Cytotoxicity and cell uptake experiments indicated that nanocarriers had low cytotoxicity against RAW 264.7 cells. Modification of HA to nanocarriers can be effectively internalized by RAW 264.7 cells stimulated by lipopolysaccharide (LPS). Combining CuS photothermal treatment with anti-atherosclerosis chemotherapy showed better effects than single treatment in vitro and in vivo. In summary, our research proved that H-CuS@DMSN-NîC-HA has broad application prospects in anti-atherosclerosis.
Subject(s)
Atherosclerosis/drug therapy , Hyaluronic Acid/therapeutic use , Multifunctional Nanoparticles/chemistry , Phototherapy , Animals , Cell Survival/drug effects , Copper/chemistry , Hyaluronic Acid/chemical synthesis , Hyaluronic Acid/chemistry , Hydrogen-Ion Concentration , Materials Testing , Mice , Nanoparticles/chemistry , Particle Size , RAW 264.7 Cells , Silicon Dioxide/chemistryABSTRACT
Alzheimer's disease (AD) is a neurodegenerative disease associated with amyloid-ß (Aß) deposition, leading to neurotoxicity (oxidative stress and neuroinflammation) and gut microbiota imbalance. Resveratrol (Res) has neuroprotective properties, but its bioavailability in vivo is very low. Herein, we developed a small Res-selenium-peptide nanocomposite to enable the application of Res for eliminating Aß aggregate-induced neurotoxicity and mitigating gut microbiota disorder in aluminum chloride (AlCl3) and d-galactose(d-gal)-induced AD model mice. Res functional selenium nanoparticles (Res@SeNPs) (8 ± 0.34 nm) were prepared first, after which the surface of Res@SeNPs was decorated with a blood-brain barrier transport peptide (TGN peptide) to generate Res-selenium-peptide nanocomposites (TGN-Res@SeNPs) (14 ± 0.12 nm). Oral administration of TGN-Res@SeNPs improves cognitive disorder through (1) interacting with Aß and decreasing Aß aggregation, effectively inhibiting Aß deposition in the hippocampus; (2) decreasing Aß-induced reactive oxygen species (ROS) and increasing activity of antioxidation enzymes in PC12 cells and in vivo; (3) down-regulating Aß-induced neuroinflammation via the nuclear factor kappa B/mitogen-activated protein kinase/Akt signal pathway in BV-2 cells and in vivo; and (4) alleviating gut microbiota disorder, particularly with respect to oxidative stress and inflammatory-related bacteria such as Alistipes, Helicobacter, Rikenella, Desulfovibrio, and Faecalibaculum. Thus, we anticipate that Res-selenium-peptide nanocomposites will offer a new potential strategy for the treatment of AD.
Subject(s)
Alzheimer Disease/drug therapy , Drug Carriers/chemistry , Nanocomposites/chemistry , Neuroprotective Agents/therapeutic use , Resveratrol/therapeutic use , Administration, Oral , Aluminum Chloride , Alzheimer Disease/chemically induced , Amyloid beta-Peptides/metabolism , Animals , Bacteria/drug effects , Drug Carriers/administration & dosage , Drug Carriers/toxicity , Galactose , Gastrointestinal Microbiome/drug effects , Immobilized Proteins/administration & dosage , Immobilized Proteins/chemistry , Immobilized Proteins/toxicity , Male , Memory/drug effects , Mice, Inbred ICR , Multifunctional Nanoparticles/administration & dosage , Multifunctional Nanoparticles/chemistry , Multifunctional Nanoparticles/toxicity , Nanocomposites/administration & dosage , Nanocomposites/toxicity , Neuroprotective Agents/administration & dosage , Neuroprotective Agents/chemistry , Oxidative Stress/drug effects , PC12 Cells , Peptide Fragments/metabolism , Peptides/administration & dosage , Peptides/chemistry , Peptides/toxicity , Protein Multimerization/drug effects , Rats , Resveratrol/administration & dosage , Resveratrol/chemistry , Selenium/administration & dosage , Selenium/chemistry , Selenium/toxicityABSTRACT
In this contribution, we report the fabrication of multifunctional nanoparticles with gold shell over an iron oxide nanoparticles (INPs) core. The fabricated system combines the magnetic property of INPs and the surface plasmon resonance of gold. The developed nanoparticles are coated with thiolated pectin (TPGINs), which provides stability to the nanoparticles dispersion and allows the loading of hydrophobic anticancer drugs. Curcumin (Cur) is used as the model drug and an encapsulation efficiency of approximately 80% in TPGINs is observed. Cytotoxicity study with HeLa cells shows that Cur-loaded TPGINs have better viability percent (~30%) than Cur alone (~40%) at a dose of 30 µg of TPGINs. Further, annexin V-PI assay demonstrated the enhanced anticancer activity of Cur-loaded TPGINs via induction of apoptosis. The use of TPGINs leads to a significant enhancement in generating reactive oxygen species (ROS) in HeLa cells through improved radiosensitization by gamma irradiation (0.5 Gy). TPGINs are further evaluated for imparting contrast in magnetic resonance imaging (MRI) with the r2 relaxivity in the range of 11.06-13.94 s-1 µg-1 mL when measured at 7 Tesla. These experimental results indicate the potential of TPGINs for drug delivery and MR imaging.
Subject(s)
Diagnostic Imaging , Multifunctional Nanoparticles/chemistry , Neoplasms/diagnostic imaging , Neoplasms/therapy , Pectins/chemistry , Radiation Tolerance , Cell Death/drug effects , Cell Survival/drug effects , Curcumin/pharmacology , Drug Liberation , Endocytosis/drug effects , HeLa Cells , Humans , Hydrodynamics , Kinetics , Magnetic Resonance Imaging , Multifunctional Nanoparticles/ultrastructure , Particle Size , Phantoms, Imaging , Photoelectron Spectroscopy , Reactive Oxygen Species/metabolism , Spectrophotometry, Ultraviolet , Spectroscopy, Fourier Transform Infrared , Spectrum Analysis, Raman , Staining and Labeling , ThermogravimetryABSTRACT
The global impact of cancer emphasizes the importance of developing innovative, effective and minimally invasive therapies. In the context of superficial cancers, the development of a multifunctional nanoparticle-based system and its in vitro and in vivo safety and efficacy characterization are, herein, proposed as a proof-of-concept. This multifunctional system consists of gold nanoparticles coated with hyaluronic and oleic acids, and functionalized with epidermal growth factor for greater specificity towards cutaneous melanoma cells. This nanoparticle system is activated by a near-infrared laser. The characterization of this nanoparticle system included several phases, with in vitro assays being firstly performed to assess the safety of gold nanoparticles without laser irradiation. Then, hairless immunocompromised mice were selected for a xenograft model upon inoculation of A375 human melanoma cells. Treatment with near-infrared laser irradiation for five minutes combined with in situ administration of the nanoparticles showed a tumor volume reduction of approximately 80% and, in some cases, led to the formation of several necrotic foci, observed histologically. No significant skin erythema at the irradiation zone was verified, nor other harmful effects on the excised organs. In conclusion, these assays suggest that this system is safe and shows promising results for the treatment of superficial melanoma.
Subject(s)
Low-Level Light Therapy/methods , Melanoma/therapy , Multifunctional Nanoparticles/therapeutic use , Skin Neoplasms/therapy , Animals , Cell Line, Tumor , Epidermal Growth Factor/chemistry , Gold/chemistry , Humans , Low-Level Light Therapy/adverse effects , Male , Melanoma/pathology , Metal Nanoparticles/chemistry , Metal Nanoparticles/therapeutic use , Mice, SCID , Multifunctional Nanoparticles/chemistry , Oleic Acid/chemistry , Proof of Concept Study , Skin Neoplasms/pathology , Xenograft Model Antitumor AssaysABSTRACT
BACKGROUND: Surgery is considered to be a potentially curative approach for gastric cancer. However, most cases are diagnosed at a very advanced stage for the lack of typical symptoms in the initial stage, which makes it difficult to completely surgical resect of tumors. Early diagnosis and precise personalized intervention are urgent issues to be solved for improving the prognosis of gastric cancer. Herein, we developed an RGD-modified ROS-responsive multifunctional nanosystem for near-infrared (NIR) imaging and photothermal therapy (PTT) against gastric cancer. METHODS: Firstly, the amphiphilic polymer was synthesized by bromination reaction and nucleophilic substitution reaction of carboxymethyl chitosan (CMCh) and 4-hydroxymethyl-pinacol phenylborate (BAPE). Then, it was used to encapsulate indocyanine green (ICG) and modified with RGD to form a smart multifunctional nanoparticle targeted to gastric cancer (CMCh-BAPE-RGD@ICG). The characteristics were determined, and the targeting capacity and biosafety were evaluated both in vitro and in vivo. Furthermore, CMCh-BAPE-RGD@ICG mediated photothermal therapy (PTT) effect was studied using gastric cancer cells (SGC7901) and SGC7901 tumor model. RESULTS: The nanoparticle exhibited suitable size (≈ 120 nm), improved aqueous stability, ROS-responsive drug release, excellent photothermal conversion efficiency, enhanced cellular uptake, and targeting capacity to tumors. Remarkably, in vivo studies suggested that CMCh-BAPE-RGD@ICG could accurately illustrate the location and margin of the SGC7901 tumor through NIR imaging in comparison with non-targeted nanoparticles. Moreover, the antitumor activity of CMCh-BAPE-RGD@ICG-mediated PTT could effectively suppress tumor growth by inducing necrosis and apoptosis in cancer cells. Additionally, CMCh-BAPE-RGD@ICG demonstrated excellent biosafety both in vitro and in vivo. CONCLUSION: Overall, our study provides a biocompatible theranostic nanoparticle with enhanced tumor-targeting ability and accumulation to realize NIR image-guided PTT in gastric cancer.
Subject(s)
Multifunctional Nanoparticles/chemistry , Multifunctional Nanoparticles/therapeutic use , Stomach Neoplasms/diagnostic imaging , Stomach Neoplasms/therapy , Animals , Boronic Acids/chemistry , Cell Line, Tumor , Chitosan/analogs & derivatives , Chitosan/chemistry , Female , Humans , Indocyanine Green/chemistry , Indocyanine Green/pharmacokinetics , Mice, Inbred BALB C , Oligopeptides/chemistry , Phototherapy/methods , Photothermal Therapy , Polymers/chemistry , Reactive Oxygen Species/metabolism , Xenograft Model Antitumor AssaysABSTRACT
BACKGROUND: Indocyanine green (ICG) has received considerable interest as a biocompatible organic photothermal agent, and curcumin (Cur) is considered an attractive natural chemopreventive and chemotherapeutic compound. However, the in vivo applicability of ICG and Cur is significantly restricted by their poor ability to target tumors and their extremely low solubility. MATERIALS AND METHODS: To address these problems, ICG/Cur-loaded albumin nanoparticles (ICG-BSA-Cur-NPs) based on the nabTM (nanoparticle albumin-bound) technology were applied to neuroblastomas in vivo. RESULTS: The fabricated ICG-BSA-Cur-NPs were found to be spherical, ~150 nm in size and highly dispersible and stable in aqueous solution. Approximately 80% of the incorporated ICG and Cur were gradually released from the NPs over 48 h. All formulations of ICG-BSA-Cur-NPs (5~20 µg/mL) showed efficient hyperthermia profiles (up to 50-60°C within 5 min) in response to 808-nm NIR laser irradiation in vitro and in vivo. Notably, ICG-BSA-Cur-NPs illuminated with 808-nm laser irradiation (1.5 W/cm2) showed excellent cytotoxicity toward N2a cells in vitro and undisputable antitumor efficacy in N2a-xenografted mice in vivo, compared to other tested sample groups (tumor volumes for PBS, BSA-Cur-NPs, free ICG, and ICG-BSA-Cur-NPs groups were 1408.6 ± 551.9, 1190.6 ± 343.6, 888.6 ± 566.2, and 103.0 ± 111.3 mm3, respectively). CONCLUSION: We demonstrate that these hyperthermal chemotherapeutic ICG-BSA-Cur-NPs have potential as a future brain tumor treatment.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Curcumin/pharmacology , Hyperthermia, Induced/methods , Indocyanine Green/pharmacology , Multifunctional Nanoparticles/chemistry , Animals , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Brain Neoplasms/pathology , Brain Neoplasms/therapy , Cell Line, Tumor , Curcumin/administration & dosage , Humans , Indocyanine Green/administration & dosage , Male , Mice, Inbred BALB C , Multifunctional Nanoparticles/administration & dosage , Neoplasms/drug therapy , Neuroblastoma/pathology , Neuroblastoma/therapy , Phototherapy/methods , Serum Albumin, Bovine/chemistry , Xenograft Model Antitumor AssaysABSTRACT
PURPOSE: A multi-functional nanoplatform with diagnostic imaging and targeted treatment functions has aroused much interest in the nanomedical research field and has been paid more attention in the field of tumor diagnosis and treatment. However, some existing nano-contrast agents have encountered difficulties in different aspects during clinical promotion, such as complicated preparation process and low specificity. Therefore, it is urgent to find a nanocomplex with good targeting effect, high biocompatibility and significant therapeutic effect for the integration of diagnosis and treatment and clinical transformation. MATERIALS AND METHODS: Nanoparticles (NPs) targeting breast cancer were synthesized by phacoemulsiï¬cation which had liquid ï¬uorocarbon perï¬uoropentane(PFP) in the core and were loaded with Iron(II) phthalocyanine (FePc) on the shell. The aptamer (APT) AS1411 was outside the shell used as a molecular probe. Basic characterization and targeting abilities of the NPs were tested, and their cytotoxicity and biological safety in vivo were evaluated through CCK-8 assay and blood bio-chemical analysis. The photoacoustic (PA) and ultrasound (US) imaging system were used to assess the effects of AS1411-PLGA@FePc@PFP (A-FP NPs) as dual modal contrast agent in vitro and in vivo. The effects of photothermal therapy (PTT) in vitro and in vivo were evaluated through MCF-7 cells and tumor-bearing nude mouse models. RESULTS: A-FP NPs, with good stability, great biocompatibility and low toxicity, were of 201.87 ± 1.60 nm in diameter, and have an active targeting effect on breast cancer cells and tissues. With the help of PA/US imaging, it was proved to be an excellent dual modal contrast agent for diagnosis and guidance of targeted therapy. Meanwhile, it can heat up under near-infrared (NIR) laser irradiation and has achieved obvious antitumor effect both in vitro and in vivo experiments. CONCLUSION: As a kind of nanomedicine, A-FP NPs can be used in the integration of diagnosis and treatment. The treatment effects and biocompatibility in vivo may provide new thoughts in the clinical transformation of nanomedicine and early diagnosis and treatment of breast cancer.
Subject(s)
Breast Neoplasms/diagnostic imaging , Breast Neoplasms/therapy , Indoles/chemistry , Multifunctional Nanoparticles/chemistry , Oligodeoxyribonucleotides/pharmacology , Animals , Aptamers, Nucleotide/administration & dosage , Aptamers, Nucleotide/chemistry , Aptamers, Nucleotide/pharmacology , Breast Neoplasms/pathology , Contrast Media/chemistry , Female , Fluorocarbons/chemistry , Humans , Iron/chemistry , Isoindoles , MCF-7 Cells , Mice, Inbred BALB C , Multifunctional Nanoparticles/administration & dosage , Oligodeoxyribonucleotides/administration & dosage , Oligodeoxyribonucleotides/chemistry , Phototherapy/methods , Polylactic Acid-Polyglycolic Acid Copolymer/chemistry , Ultrasonography , Xenograft Model Antitumor AssaysABSTRACT
PURPOSE: Focused ultrasound (FUS) is a noninvasive method to produce thermal and mechanical destruction along with an immune-stimulatory effect against cancer. However, FUS ablation alone appears insufficient to generate consistent antitumor immunity. In this study, a multifunctional nanoparticle was designed to boost FUS-induced immune effects and achieve systemic, long-lasting antitumor immunity, along with imaging and thermal enhancement. MATERIALS AND METHODS: PEGylated PLGA nanoparticles encapsulating astragalus polysaccharides (APS) and gold nanorods (AuNRs) were constructed by a simple double emulsion method, characterized, and tested for cytotoxicity. The abilities of PA imaging and thermal-synergetic ablation efficiency were analyzed in vitro and in vivo. The immune-synergistic effect on dendritic cell (DC) differentiation in vitro and the immune response in vivo were also evaluated. RESULTS: The obtained APS/AuNR/PLGA-PEG nanoparticles have an average diameter of 255.00±0.1717 nm and an APS-loading efficiency of 54.89±2.07%, demonstrating their PA imaging capability and high biocompatibility both in vitro and in vivo. In addition, the as-prepared nanoparticles achieved a higher necrosis cell rate and induced apoptosis rate in an in vitro cell suspension assay, greater necrosis area and decreased energy efficiency factor (EEF) in an in vivo rabbit liver assay, and remarkable thermal-synergic performance. In particular, the nanoparticles upregulated the expression of MHC-II, CD80 and CD86 on cocultured DCs in vitro, followed by declining phagocytic function and enhanced interleukin (IL)-12 and interferon (INF)-γ production. Furthermore, they boosted the production of tumor necrosis factor (TNF)-α, IFN-γ, IL-4, IL-10, and IgG1 (P< 0.001) but not IgG2a. Immune promotion peaked on day 3 after FUS in vivo. CONCLUSION: The multifunctional APS/AuNR/PLGA-PEG nanoparticles can serve as an excellent synergistic agent for FUS therapy, facilitating real-time imaging, promoting thermal ablation effects, and boosting FUS-induced immune effects, which have the potential to be used for further clinical FUS treatment.
Subject(s)
Astragalus Plant/chemistry , Breast Neoplasms/therapy , Gold/chemistry , Multifunctional Nanoparticles/chemistry , Nanotubes/chemistry , Polysaccharides/chemistry , Ultrasonic Therapy , Animals , Antigens, CD/metabolism , Apoptosis , Cell Death , Cell Differentiation , Cell Line, Tumor , Cell Proliferation , Cytokines/metabolism , Dendritic Cells/cytology , Female , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Immunoglobulin G/metabolism , Lymphocytes, Tumor-Infiltrating/immunology , Mice, Inbred BALB C , Phagocytosis , Photoacoustic Techniques , Polyesters/chemical synthesis , Polyesters/chemistry , Polyethylene Glycols/chemical synthesis , Polyethylene Glycols/chemistry , Rabbits , Theranostic Nanomedicine , Vascular Endothelial Growth Factor A/metabolismABSTRACT
Smart multifunctional nanoparticles with magnetic and plasmonic properties assembled on a single nanoplatform are promising for various biomedical applications. Owing to their expanding imaging and therapeutic capabilities in response to external stimuli, they have been explored for on-demand drug delivery, image-guided drug delivery, and simultaneous diagnostic and therapeutic (i.e. theranostic) applications. In this study, we engineered nanoparticles with unique morphology consisting of a superparamagnetic iron oxide core and star-shaped plasmonic shell with high-aspect-ratio gold branches. Strong magnetic and near-infrared (NIR)-responsive plasmonic properties of the engineered nanostars enabled multimodal quantitative imaging combining advantageous functions of magnetic resonance imaging (MRI), magnetic particle imaging (MPI), photoacoustic imaging (PAI), and image-guided drug delivery with a tunable drug release capacity. The model drug molecules bound to the core-shell nanostars were released upon NIR illumination due to the heat generation from the core-shell nanostars. Moreover, our simulation analysis showed that the specific design of the core-shell nanostars demonstrated a pronounced multipolar plasmon resonance, which has not been observed in previous reports. The multimodal imaging and NIR-triggered drug release capabilities of the proposed nanoplatform verify their potential for precise and controllable drug release with different applications in personalized medicine.
Subject(s)
Drug Delivery Systems/methods , Magnetite Nanoparticles/chemistry , Multifunctional Nanoparticles/chemistry , Animals , Drug Liberation/physiology , Electromagnetic Phenomena , Ferric Compounds/chemistry , Gold , Humans , Magnetic Resonance Imaging , Magnetics , Multifunctional Nanoparticles/therapeutic use , Multimodal Imaging , Phototherapy/methods , Precision Medicine/methodsABSTRACT
PURPOSE: Chemotherapy in head and neck squamous cell carcinoma (HNSCC) has many systemic side effects, as well as hypoxia-induced chemoresistance. To reduce side effects and enhance chemosensitivity are urgently needed. METHODS: We synthesized a drug delivery system (named CECMa NPs) based on cisplatin (CDDP) and metformin (chemotherapeutic sensitizer), of which chlorin e6 (Ce6) and polyethylene glycol diamine (PEG) were synthesized as the shell, an anti-LDLR antibody (which can target to hypoxic tumor cells) was modified on the surface to achieve tumor targeting. RESULTS: The NPs possessed a great synergistic effect of chemotherapy and phototherapy. After laser stimulation, both CDDP and metformin can be released in situ to achieve anti-tumor effects. Meanwhile, PDT and PTT triggered by a laser have anticancer effects. Furthermore, compared with free cisplatin, CECMa exhibits less systemic toxicity with laser irradiation in the xenograft mouse tumor model. CONCLUSION: CECMa effectively destroyed the tumors via hypoxia targeting multimodal therapy both in vitro and in vivo, thereby providing a novel strategy for targeting head and neck squamous cell carcinoma.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Head and Neck Neoplasms/therapy , Multifunctional Nanoparticles/chemistry , Squamous Cell Carcinoma of Head and Neck/therapy , Animals , Cell Line, Tumor , Chlorophyllides , Cisplatin/administration & dosage , Cisplatin/pharmacology , Combined Modality Therapy , Drug Delivery Systems , Head and Neck Neoplasms/pathology , Humans , Male , Metformin/administration & dosage , Metformin/pharmacology , Mice, Inbred BALB C , Multifunctional Nanoparticles/administration & dosage , Multifunctional Nanoparticles/therapeutic use , Photochemotherapy , Phototherapy/methods , Polyethylene Glycols/chemistry , Porphyrins/chemistry , Squamous Cell Carcinoma of Head and Neck/pathology , Tumor Hypoxia/drug effects , Xenograft Model Antitumor AssaysABSTRACT
As a member of flavonoids, the application of quercetin has been mainly focused on antioxidation study. Fabrication of multifunctional nanoplatforms with quercetin is limited. In the present study, water-soluble quercetin derived nanoparticles (QFNPs) were fabricated through the one pot synthesis strategy with Fe3+, quercetin and poly (vinyl pyrrolidone) (PVP). The raw materials were dissolved in absolute ethanol and the mixed together. After stirring at room temperature for 6â¯h, the QFNPs could be simply harvested by centrifugation without the need of time-consuming dialysis procedure. Due to the protective effect of PVP, the synthesized nanoparticles could be well dispersed in water with the hydrodynamic size about 23â¯nm. DPPH free radical scavenging capacity assay showed QFNPs could act as efficient antioxidant. Besides antioxidation activity, the QFNPs also exhibited good photothermal capacity. Temperature stability result suggested the good stability of QFNPs between 35 and 95⯰C. MTT and hemolysis assay showed the good biocompatibility of QFNPs. What's more, the QFNPs showed good cellular antioxidation activity and efficient photothermal killing effect to cancer cells (4T1 cells). The QFNPs could be promising nanoplatform for biomedical application.
Subject(s)
Antioxidants/pharmacology , Drug Carriers , Epithelial Cells/drug effects , Multifunctional Nanoparticles/chemistry , Povidone/chemistry , Quercetin/pharmacology , Animals , Antioxidants/chemistry , Antioxidants/radiation effects , Biphenyl Compounds/antagonists & inhibitors , Biphenyl Compounds/chemistry , Cell Line, Tumor , Epithelial Cells/pathology , Epithelial Cells/radiation effects , Female , Hot Temperature , Hyperthermia, Induced/methods , Light , Mammary Glands, Animal/pathology , Mice , Multifunctional Nanoparticles/radiation effects , Multifunctional Nanoparticles/ultrastructure , Particle Size , Picrates/antagonists & inhibitors , Picrates/chemistry , Quercetin/chemistry , Quercetin/radiation effects , Solubility , Water/chemistryABSTRACT
Strategies that control the differentiation of mesenchymal stem cells (MSC) and enable image-guided cell implantation and longitudinal monitoring could advance MSC-based therapies for bone defects and injuries. Here we demonstrate a multifunctional nanoparticle system that delivers resveratrol (RESV) intracellularly to improve osteogenesis and enables photoacoustic imaging of MSCs. RESV-loaded nanoparticles (RESV-NPs), formulated from poly (lactic-co-glycolic) acid and iron oxide, enhanced the stability of RESV by 18-fold and served as photoacoustic tomography (PAT) contrast for MSCs. Pre-loading MSCs with RESV-NP upregulated RUNX2 expression with a resultant increase in mineralization by 27% and 45% compared to supplementation with RESV-NP and free RESV, respectively, in 2-dimensional cultures. When grown in polyethylene glycol-based hydrogels, MSCs pre-loaded with RESV-NPs increased the overall level and homogeneity of mineralization compared to those supplemented with free RESV or RESV-NP. The PAT detected RESV-NP-loaded MSCs with a resolution of 1500 cells/µL, which ensured imaging of MSCs upon encapsulation in a PEG-based hydrogel and implantation within the rodent cranium. Significantly, RESV-NP-loaded MSCs in hydrogels did not show PAT signal dilution over time or a reduction in signal upon osteogenic differentiation. This multifunctional NP platform has the potential to advance translation of stem cell-based therapies, by improving stem cell function and consistency via intracellular drug delivery, and enabling the use of a promising emerging technology to monitor cells in a clinically relevant manner.
Subject(s)
Drug Delivery Systems , Ferric Compounds/administration & dosage , Mesenchymal Stem Cells/drug effects , Multifunctional Nanoparticles/administration & dosage , Photoacoustic Techniques , Resveratrol/administration & dosage , Animals , Cell Line , Ferric Compounds/chemistry , Humans , Magnetic Resonance Imaging , Multifunctional Nanoparticles/chemistry , Osteogenesis/drug effects , Rats , Resveratrol/chemistryABSTRACT
Despite multifunctional nanoparticles using for photothermal therapy can efficiently kill cancer cells, their further application is still hindered by the intrinsic high uptake in the reticuloendothelial system (RES) organs, causing the slow elimination from the body and potential toxicity to the body. Therefore, it is ideal to develop multifunctional nanoparticles which process the ability to effectively accumulate in tumors, while the nanoparticles can be rapidly excreted from the body via renal clearance after effective treatment. Herein, we report the multifunctional nanoparticles (FeTNPs) based on the coordination interaction of phenolic group and metal iron, which are composed of ferric iron, tannic acid (TA) and poly (glutamic acid)-graft-methoxypoly (ethylene glycol) (PLG-g-mPEG). FeTNPs exhibit the following highlighted features: (1) The effective accumulation in the tumor tissue is achieved based on EPR effect. (2) The dual photoacoustic (PA)/magnetic resonance (MR) imaging capacity can provide guidance for the photothermal therapy (PTT). (3) FeTNPs can be dynamically disassembled by deferoxamine mesylate (DFO) to accelerate elimination of the nanoparticles, thus reducing the potential toxicity for the body. The DFO triggered dynamic disassembling strategy may open a new avenue to overcome the dilemma between EPR effect and renal clearance.